glp-1 chronic fatigue syndrome Explained: Why You're Tired & How to Fix It (2026) GLP-1 Receptor Agonists, MCAS and

However, this risk increases when Ozempic is used in combination with insulin or sulfonylureas

Alarmingly, around 63% of individuals stop GLP-1 injections within the first month, primarily due to adverse side effects such as nausea, gastrointestinal discomfort, and cost-related factors

Walk for 15 minutes after breakfast

According to Grand View Research, specifically for GLP-1 weight-loss, the market size in 2025 is about $20.86 billion, expected to grow to $48.84 billion by 2030, with a CAGR of ~18.5%

In SELECT, a trial of more than 17,000 people on semaglutide, serious adverse events were actually lower than on placebo, about 33 percent versus 36 percent (Lincoff et al., 2023)